Latest Healthcare News

Medibank Private Limited reported a robust FY25 with an 8.5% rise in underlying net profit after tax and an 8.4% increase in fully franked dividends, driven by growth in both resident and non-resident health insurance segments and expanding health services.

SDI Limited’s FY25 results reveal steady revenue with improved margins driven by operational efficiencies and strong European and Brazilian sales. The company is progressing its Montrose facility project and advancing ESG initiatives.

SDI Limited reported a 16.7% rise in net profit after tax for FY2025, driven by improved gross margins and operational efficiencies despite a slight sales dip. The company maintained its dividend while investing in automation and new product development.

SDI Limited reported a 16.7% rise in net profit to $12.2 million for FY2025, maintaining dividends amid mixed regional sales and margin gains. The company plans significant production automation and facility redevelopment to drive future growth.

CurveBeam AI Limited reported a striking 86% revenue increase to $12.1 million in FY25, alongside a 27% reduction in net loss, signaling improving financial health despite ongoing challenges with its HiRise device validation.

Doctor Care Anywhere has reported a profitable first half of 2025, driven by strong margin improvements and operational efficiencies. The telehealth provider’s strategic expansion and app enhancements signal promising growth ahead.

Doctor Care Anywhere Group PLC has reported its first-ever profit for the six months ended June 2025, marking a pivotal turnaround driven by operational efficiencies and pricing strategies despite a revenue dip.

CurveBeam AI Limited posted a strong 85% increase in revenue to $12.1 million for FY25, alongside a reduced net loss of $16.8 million. Despite operational improvements and a recent $11.58 million capital raise, the company flags material uncertainty over its ability to continue as a going concern.

Medibank has reported strong full-year results for 2025, with underlying net profit rising 8.5% and record policyholder growth, underpinned by disciplined cost management and strategic health investments.

Medibank Private Limited reported steady revenue growth and stable profit for FY25, while navigating ongoing cybercrime-related expenses and regulatory scrutiny. The insurer also announced increased dividends and outlined strategic investments in health services and digital transformation.

ImpediMed Limited has posted a 23% increase in revenue for the 2025 financial year, yet its net loss widened by 17%, with no dividends declared. The company’s financials, audited by Ernst & Young, reveal a complex picture of growth paired with escalating costs.

Trajan Holdings delivered solid FY2025 results with revenue up 7.4% to $166.5 million and improved profitability despite transient costs and a biotech syringe loss. The company refinanced debt and set an optimistic FY2026 guidance range.